Resources from the same session
Utility of more comprehensive sequencing to identify biomarkers for early phase clinical trials
Presenter: Michael Berger
Session: The evolving diagnostic landscape of early phase trials
Resources:
Slides
Webcast
Challenges of HLA, neoantigen, and immune biomarker testing for early phase immunomodulatory therapy trials
Presenter: Michal Bassani-Sternberg
Session: The evolving diagnostic landscape of early phase trials
Resources:
Webcast
Expanding proteome interrogation to identify early phase clinical trial biomarkers
Presenter: Janne Lehtiö
Session: The evolving diagnostic landscape of early phase trials
Resources:
Slides
Webcast
AI and machine learning to identify early phase clinical trial biomarkers
Presenter: Jakob Kather
Session: The evolving diagnostic landscape of early phase trials
Resources:
Slides
Webcast
Q&A and discussion
Session: The evolving diagnostic landscape of early phase trials
Resources:
Webcast